Distinct mechanisms for activation of the opioid receptor-like 1 and κ-opioid receptors by nociceptin and dynorphin A

被引:71
作者
Mollereau, C [1 ]
Mouledous, L [1 ]
Lapalu, S [1 ]
Cambois, G [1 ]
Moisand, C [1 ]
Butour, JL [1 ]
Meunier, JC [1 ]
机构
[1] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France
关键词
D O I
10.1124/mol.55.2.324
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To understand how two structurally analogous ligand-receptor systems, the nociceptin/opioid receptor-like 1 (ORL1) and dynorphin A/kappa-opioid receptor 1 (KOR1) systems, achieve selectivity, receptor chimeras were generated and analyzed. Replacing discrete domains located between the N-terminus and top of the third transmembrane helix of the KOR1 by the homologous domains of the ORL1 receptor yields hybrid receptors, which, in comparison with the parent KOR1, display up to 300-fold increased affinity but low sensitivity toward nociceptin, and unaltered (high) affinity and sensitivity toward dynorphin A. These substitutions contribute elements for binding of nociceptin but do not suppress determinants necessary for binding and potency of dynorphin A. More importantly, further replacement in these chimeras of the second extracellular loop with that of the ORL1 receptor fully restores responsiveness to nociceptin without impairing responsiveness to dynorphin A. A bifunctional hybrid receptor has thus been identified that binds and responds to both nociceptin and dynorphin A as efficiently as the ORL1 receptor does to nociceptin and the KOR1 to dynorphin A. Together, these results suggest that distinct peptide activation mechanisms operate in the two receptor systems. In particular, the second extracellular receptor loop appears to be an absolute requirement for activation of the ORL1 receptor by nociceptin, but not for activation of the KOR1 by dynorphin A.
引用
收藏
页码:324 / 331
页数:8
相关论文
共 39 条
  • [1] Extracellular domains of the bradykinin B2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies
    Alla, SA
    Quitterer, U
    Grigoriev, S
    Maidhof, A
    Haasemann, M
    Jarnagin, K
    MullerEsterl, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (03) : 1748 - 1755
  • [2] A SEPARATION METHOD FOR THE ASSAY OF ADENYLYLCYCLASE, INTRACELLULAR CYCLIC-AMP, AND CYCLIC-AMP PHOSPHODIESTERASE USING TRITIUM-LABELED SUBSTRATES
    ALVAREZ, R
    DANIELS, DV
    [J]. ANALYTICAL BIOCHEMISTRY, 1992, 203 (01) : 76 - 82
  • [3] Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition
    Befort, K
    Tabbara, L
    Kling, D
    Maigret, B
    Kieffer, BL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) : 10161 - 10168
  • [4] Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids
    Butour, JL
    Moisand, C
    Mazarguil, H
    Mollereau, C
    Meunier, JC
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 321 (01) : 97 - 103
  • [5] Nociceptin, and endogenous ligand for the ORL(1) receptor, has novel hypotensive activity in the rat
    Champion, HC
    Kadowitz, PJ
    [J]. LIFE SCIENCES, 1997, 60 (16) : PL241 - PL245
  • [6] SPECIFIC RECEPTOR FOR THE OPIOID PEPTIDE DYNORPHIN - STRUCTURE-ACTIVITY-RELATIONSHIPS
    CHAVKIN, C
    GOLDSTEIN, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (10): : 6543 - 6547
  • [7] HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA
    CHEN, C
    OKAYAMA, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) : 2745 - 2752
  • [8] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [9] Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ
    Devine, DP
    Taylor, L
    Reinscheid, RK
    Monsma, FJ
    Civelli, O
    Akil, H
    [J]. NEUROCHEMICAL RESEARCH, 1996, 21 (11) : 1387 - 1396
  • [10] Devine DP, 1996, BRAIN RES, V727, P225